---
schema_version: "secwatch.filing_event.v1"
accession: "0001854270-25-000008"
form_type: "8-K"
ticker: "SNTI"
cik: "0001854270"
company_name: "Senti Biosciences, Inc."
filed_at: "2025-02-25T23:59:59+00:00"
generated_at: "2026-05-26T04:57:24.324516+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Senti Bio appoints Jay Cross as CFO and Faraz Siddiqui as SVP Technical Operations

## Summary
- Jay Cross appointed CFO effective March 3, 2025; base salary $465k, annual target bonus 40%, sign-on bonus $50k repayable if leaving before 14 months.
- Stock option for 174,200 shares (or 44,000 if stockholder proposal fails) under 2022 Inducement Plan; four-year vesting.
- Faraz Siddiqui joined as SVP Technical Operations in Jan 2025; oversees manufacturing, supply chain; previously at IGM Biosciences, Instil Bio, Kite Pharma, Genentech.
- CEO Timothy Lu served as interim principal financial officer from Jan 31 until 10-K filing when Cross assumes role.

## SEC filing metadata
- accession: 0001854270-25-000008
- form_type: 8-K
- ticker: SNTI
- cik: 0001854270
- company_name: Senti Biosciences, Inc.
- filed_at: 2025-02-25T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1854270/000185427025000008/0001854270-25-000008-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1854270/000185427025000008/snti-20250223.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001854270-25-000008
- JSON: https://secwatch.observer/filing/0001854270-25-000008.json
- Plain text: https://secwatch.observer/filing/0001854270-25-000008.txt

## Key facts
- Executive change
  Jay Cross was appointed as Chief Financial Officer at Senti Biosciences, Inc..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: Jay Cross was appointed as the Company’s Chief Financial Officer, effective as of March 3, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1854270/000185427025000008/0001854270-25-000008-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.